Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor

MLA

Sharon J. Diskin, et al. “Fine Mapping of 2q35 High-Risk Neuroblastoma Locus Reveals Independent Functional Risk Variants and Suggests Full-Length BARD1 as Tumor-Suppressor.” International Journal of Cancer, vol. 143, Oct. 2018, pp. 2828–37. EBSCOhost, https://doi.org/10.1002/ijc.31822.

APA

Sharon J. Diskin, Zalman Vaksman, John M. Maris, Piero Pignataro, Alessandro Testori, Daniela Formicola, Jan Koster, Carmen Torres, Antonella Cardinale, Marianna Avitabile, Achille Iolascon, Flora Cimmino, Mario Capasso, & Marcella Devoto. (2018). Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor. International Journal of Cancer, 143, 2828–2837. https://doi.org/10.1002/ijc.31822

Chicago

Sharon J. Diskin, Zalman Vaksman, John M. Maris, Piero Pignataro, Alessandro Testori, Daniela Formicola, Jan Koster, et al. 2018. “Fine Mapping of 2q35 High-Risk Neuroblastoma Locus Reveals Independent Functional Risk Variants and Suggests Full-Length BARD1 as Tumor-Suppressor.” International Journal of Cancer 143 (October): 2828–37. doi:10.1002/ijc.31822.